Hypertension Risk Factors: Non-Modifiable and Modifiable Causes of High Blood Pressure
Hypertension (HTN) affects ~1.3 billion adults globally. It arises from interacting genetic, environmental, and lifestyle factors. Identifying modifiable risks enables prevention and control.
Non-Modifiable Risk Factors
- Age: Arterial stiffening → ↑ systolic BP; prevalence >60% at age 60+
- Genetics/Family history: Polygenic; ~30–50% heritable; GWAS identifies >1,000 loci
- Race/Ethnicity: Black adults: earlier onset, higher severity, salt sensitivity, worse outcomes (driven by structural/social determinants)
- Sex: Men <65 > women; post-menopause women catch up or surpass
Modifiable Risk Factors
- Obesity (BMI ≥30): ↑ insulin resistance → renal Na⁺ retention → ↑ volume; adipokines, SNS activation; weight loss 5–10% → ↓5–20 mmHg systolic
- Physical inactivity: ↑ SNS, ↓ NO, ↑ stiffness; 150 min/week moderate → ↓4–9 mmHg
- Diet:
- High sodium (>2.3g/day Na⁺) → volume expansion
- Low potassium (<3.5g/day) → ↓ natriuresis
- Low fruit/veg (DASH diet ↓11 mmHg systolic)
- Alcohol: >2 drinks/day men, >1 women → ↑ BP dose-dependently
- Tobacco: Acute vasoconstriction; chronic endothelial dysfunction
- Sleep apnea: Intermittent hypoxia → SNS/RAAS activation; CPAP ↓ BP
- Stress: Chronic SNS/HPA activation; psychosocial stressors
Secondary Hypertension (5–10% of Cases)
- Chronic kidney disease (most common)
- Primary aldosteronism (screen if resistant HTN)
- Renovascular disease, Cushing's, pheochromocytoma, thyroid/parathyroid disorders
- Drug-induced: NSAIDs, oral contraceptives, steroids, stimulants, licorice, immunosuppressants
Clinical Approach
- Accurate measurement (validated device, proper technique, average ≥2 readings on ≥2 visits)
- Assess global CV risk (ASCVD score, target organ damage)
- Screen for secondary causes if resistant, young, hypokalemic, or suggestive features
- Lifestyle prescription first (unless Stage 2 or high risk)
- Pharmacotherapy per guideline (ACEi/ARB, CCB, thiazide, β-blocker)
Hypertension is the leading modifiable risk factor for CVD. Population-level sodium reduction and individual risk factor control are public health priorities.
Hypertension - Related Articles
- Aldactone Side Effects: Ringing in Ears & What You Need to Know
- Understanding High Blood Pressure: Causes, Risks & Prevention
- Understanding Blood Pressure: Systolic & Diastolic Explained
- Blood Pressure Targets for Men Aged 43–49: Maintaining Heart Health
- The Baroreflex: How Blood Pressure Drops Trigger Heart Rate Increases
- Naturally Lower Blood Pressure: Foods That Help
- Norvasc (Amlodipine): Risks, Side Effects & Important Precautions
